| 摘要 |
<p>The present invention is directed to pharmaceutical compositions containing active compounds, which inhibit the activity of the chemokines, MIP-lα and RANTES. It also is directed to methods of treating inflammatory and immunoregulatory disorders and diseases using these pharmaceutical compositions.</p> |
